Pharmafile Logo

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

May 22, 2025 |  

- PMLiVE

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next generation of oncology professionals advancing clinical practice and improving patient outcomes 

Fellows Program Returns—Stronger Than Ever

The Medscape ASCO Fellows Program is back for its second year, offering hematology/oncology fellows a chance to:

  • Participate in exclusive focus groups with Medscape Oncology
  • Attend and network with expert faculty at our symposia
  • Share their ASCO experiences live from the Medscape Studio

“We’re thrilled to bring the Fellows Program back to ASCO. This initiative not only supports the next generation of oncologists but also helps them engage in meaningful learning and connect directly with leaders in the field,” said Jelena Spyropoulos 

If you’re passionate about advancing cancer care, Medscape Oncology at ASCO 2025 is the place to be. Join us as we deliver education that drives change—because informed clinicians mean better outcomes for patients.

7 Symposia! Where Science Meets Practice:

This year’s Medscape Oncology symposia go beyond the latest data—they’re designed to translate emerging science into actionable clinical strategies for real-world practice. Here’s a look at what’s in store:

  • Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science into Clinical Practice– Explore how tumor-agnostic therapies are reshaping precision oncology through earlier detection and personalized treatment.

 

  • Myelofibrosis: Clinical Updates and Best Practices for the Community Hematology/Oncology Clinic: Updates for the Community Hematology/Oncology Clinic- Stay ahead with the latest in therapies, risk tools, and symptom management tailored for community practice.

 

  • The Gynecologic Oncology Clinic: Real-time Case Review of Patients With Endometrial or Ovarian Cancer: Walk through real patient cases with expert faculty to enhance your approach to diagnosing and treating gynecologic cancers.


  • Clinical Integration of Therapeutic Innovations in Glioma: Pathways to Improved Patient Outcomes: Explore how cutting-edge treatments are transforming glioma care—and how to apply them in practice.


  • Bispecific Antibodies in R/R FL and R/R DLBCL: Aligning on Clinical Best Practices Learn to leverage bispecific antibodies in relapsed/refractory lymphomas with emerging best practices.


  • Changing Your Practice in Squamous Cell Carcinoma of the Anal Canal: Uncover how new therapies and biomarkers are redefining standards in this underserved cancer type.


  • A Day in the Community Oncology Clinic: Exploring Molecularly Altered NSCLC: Explore real-world cases that showcase the impact of biomarker-driven treatments in NSCLC.

Register for the symposia here

Each session is built for clinical relevance, interactivity, and practical insights, so learners leave with tools they can apply immediately. All symposia will also be available for CME/CE credit at Medscape.org.

Elevating Education with Data-Driven Outcomes

Medscape Oncology will also debut three new e-publications on the ASCO website, showcasing the measurable impact of our programs on findings from a comprehensive patient survey on nonmelanoma skin cancer and breast cancer education. These publications demonstrate how education can drive real-world improvements in care.

  1. Patient perspectives on nonmelanoma skin cancer care: insights into treatment, barriers, and healthcare gaps –https://meetings.asco.org/abstracts-presentations/248219
  2. Enhancing care of patients with HR+/HER2- early breast cancer at high risk of recurrence through an expansive curriculum: real-world outcomes (RWO) a 6-month analysis https://meetings.asco.org/abstracts-presentations/244642
  3. Is increase in CME consumption associated with practice change in the real world? An empirical study among oncologists treating breast cancer https://meetings.asco.org/abstracts-presentations/248318

Want to learn more?

Contact Jelena Spyropoulos (jspyropoulos@medsacpe.net) for details on Medscape Oncology and our full ASCO 2025 programming.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a supervisory role. But for two pioneering NPs, Laura Demuth and Jackie...

Voices of Change: Women Leading the Menopause Movement

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as something women just had to “get past” and hardly worth...

Medscape Wins Anthem Award for Rare Disease Education Platform

Platform has reached 2.4 million healthcare professionals worldwide since 2021. Newark, NJ - [November 18, 2025] - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been...

Shifting the Paradigm: A New Era for Parkinson’s Care

In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...